Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
Supplementary Data
Supplementary Data
Files in this Data Supplement:
Supplementary Data
- Docx file
Supplementary Figure 1
- tif file